Neurofilament light-chain (NfL) and 18 kDa translocator protein in early psychosis and its putative high-risk
Evidence of elevated peripheral Neurofilament light-chain (NfL) as a biomarker of neuronal injury can be utilized to reveal nonspecific axonal damage, which could reflect altered neuroimmune function. To date, only a few studies have investigated NfL as a fluid biomarker in schizophrenia primarily,...
Main Authors: | Kankana Nisha Aji, Giulia Cisbani, Ana Weidenauer, Alex Koppel, Sina Hafizi, Tania Da Silva, Michael Kiang, Pablo M. Rusjan, Richard P. Bazinet, Romina Mizrahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-05-01
|
Series: | Brain, Behavior, & Immunity - Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666354624000206 |
Similar Items
-
Interaction between peripheral and central immune markers in clinical high risk for psychosis
by: Kankana Nisha Aji, et al.
Published: (2023-07-01) -
Personality traits in psychosis and psychosis risk linked to TSPO expression: a neuroimmune marker
by: Cory Gerritsen, et al.
Published: (2020-01-01) -
Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01) -
Plasma Neurofilament Light (NfL) in Patients Affected by Niemann–Pick Type C Disease (NPCD)
by: Andrea Dardis, et al.
Published: (2021-10-01) -
Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy
by: Zhang Q, et al.
Published: (2023-01-01)